SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eclectus who wrote (722)3/2/2000 9:35:00 PM
From: Timoteo  Read Replies (1) of 1298
 
CEGE is worth $100 meaning that it will probably go to $300 in this market. I have been adding to my position since $23 including more today @ $57. By any measure CEGE is the best buy in biotechnology. The cash is really the key in that business and they have it. I also sold many good companies too soon: LSI, Periphonics, DIO, CUBE to name a few that tripled on me afterwards. Biotechnology will be the sector this year IMO and CEGE's stock price will be the beneficiary. I'm sure a lot of people sold Dell, Cisco and AMAT after they made a four or five bagger. There is still alot of money to be made here.

Best,

Timoteo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext